Skip to main content
Contact Us
Subscribe
E-Edition
47°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
KalVista Pharmaceuticals, Inc. - Common Stock
(NQ:
KALV
)
8.760
UNCHANGED
Streaming Delayed Price
Updated: 1:00 PM EST, Dec 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about KalVista Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 24, 2024
Via
Benzinga
This Box Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
December 18, 2024
Via
Benzinga
Super Micro Computer And Other Big Stocks Moving Lower In Monday's Pre-Market Session
December 16, 2024
Via
Benzinga
NVIDIA To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Friday
July 12, 2024
Via
Benzinga
KALV Stock Earnings: KalVista Pharma Misses EPS for Q4 2024
July 11, 2024
KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the fourth quarter of 2024.
Via
InvestorPlace
Recap: KalVista Pharma Q3 Earnings
March 11, 2024
Via
Benzinga
Insiders Buying Dorian LPG And 2 Other Stocks
January 17, 2024
Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.
Via
Benzinga
KalVista Pharma: Q2 Earnings Insights
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
February 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 14, 2024
Via
Benzinga
Citigroup To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Wednesday
February 14, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday?
February 13, 2024
Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema.
Via
Benzinga
Recap: KalVista Pharma Q4 Earnings
July 07, 2023
Via
Benzinga
Analyst Expectations for KalVista Pharma's Future
April 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 13, 2024
Via
Benzinga
Insiders Buying Monro And 3 Other Stocks
February 09, 2024
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
February 02, 2024
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
January 30, 2024
Although U.S. stocks closed higher on Monday, there were a few notable insider trades.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
Via
Benzinga
$230M Bet On Talos Energy? Check Out These 4 Stocks Insiders Are Buying
January 22, 2024
Although U.S. stocks closed higher on Friday, there were a few notable insider trades.
Via
Benzinga
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
January 11, 2024
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.
Via
Benzinga
$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
January 08, 2024
Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades.
Via
Benzinga
Around $2.4M Bet On HighPeak Energy? Check Out These 4 Stocks Insiders Are Buying
January 02, 2024
Although U.S. stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
KALV Stock Earnings: KalVista Pharma Misses EPS for Q2 2024
December 07, 2023
KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
3 Micro-Cap Stocks That Could Be Moonshots
November 14, 2023
If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 27, 2023
Via
Benzinga
Gold Rises Over 1%; Elys Game Technology Shares Spike Higher
December 27, 2022
U.S. stocks traded mixed toward the end of trading, with the Dow Jones trading slightly higher on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 27, 2022
Via
Benzinga
Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
December 27, 2022
Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C.
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.